# Schwab Charles Corp: financial statements, quarterly

SCHW · NYSE · CIK 316709 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/schw.md) · [Financials](/companies/schw/financials.md) · [Filings](/companies/schw/filings.md) · [Insiders](/companies/schw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/schw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,606](/filings/0000316709-24-000069.md) | [4,459 d](/filings/0000316709-26-000009.md) | [4,740](/filings/0000316709-25-000023.md) | [4,690](/filings/0000316709-25-000039.md) | [4,847](/filings/0000316709-25-000051.md) | [5,329 d](/filings/0000316709-26-000009.md) | [5,599](/filings/0000316709-26-000019.md) | [5,851](/filings/0000316709-26-000031.md) | [6,135](/filings/0000316709-25-000051.md) | [6,336 d](/filings/0000316709-26-000009.md) | [6,482](/filings/0000316709-26-000019.md) | [7,072](/filings/0000316709-26-000031.md) |
| Interest expense | $m | [1,791](/filings/0000316709-24-000069.md) | [1,833 d](/filings/0000316709-24-000018.md) | [1,708](/filings/0000316709-24-000044.md) | [1,659](/filings/0000316709-24-000060.md) | [1,706](/filings/0000316709-24-000069.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [258](/filings/0000316709-24-000069.md) | [149 d](/filings/0000316709-26-000009.md) | [436](/filings/0000316709-25-000023.md) | [415](/filings/0000316709-25-000039.md) | [434](/filings/0000316709-25-000051.md) | [465 d](/filings/0000316709-26-000009.md) | [546](/filings/0000316709-26-000019.md) | [677](/filings/0000316709-26-000031.md) | [663](/filings/0000316709-25-000051.md) | [721 d](/filings/0000316709-26-000009.md) | [709](/filings/0000316709-26-000019.md) | [869](/filings/0000316709-26-000031.md) |
| Net income | $m | [1,125](/filings/0000316709-24-000069.md) | [1,045 d](/filings/0000316709-26-000009.md) | [1,362](/filings/0000316709-25-000023.md) | [1,332](/filings/0000316709-25-000039.md) | [1,408](/filings/0000316709-25-000051.md) | [1,840 d](/filings/0000316709-26-000009.md) | [1,909](/filings/0000316709-26-000019.md) | [2,126](/filings/0000316709-26-000031.md) | [2,358](/filings/0000316709-25-000051.md) | [2,459 d](/filings/0000316709-26-000009.md) | [2,479](/filings/0000316709-26-000019.md) | [2,800](/filings/0000316709-26-000031.md) |
| Diluted EPS | $ per share | [0.56](/filings/0000316709-24-000069.md) | not reported | [0.68](/filings/0000316709-25-000023.md) | [0.66](/filings/0000316709-25-000039.md) | [0.71](/filings/0000316709-25-000051.md) | not reported | [0.99](/filings/0000316709-26-000019.md) | [1.08](/filings/0000316709-26-000031.md) | [1.26](/filings/0000316709-25-000051.md) | not reported | [1.37](/filings/0000316709-26-000019.md) | [1.54](/filings/0000316709-26-000031.md) |
| Basic EPS | $ per share | [0.56](/filings/0000316709-24-000069.md) | not reported | [0.69](/filings/0000316709-25-000023.md) | [0.66](/filings/0000316709-25-000039.md) | [0.71](/filings/0000316709-25-000051.md) | not reported | [0.99](/filings/0000316709-26-000019.md) | [1.09](/filings/0000316709-26-000031.md) | [1.26](/filings/0000316709-25-000051.md) | not reported | [1.37](/filings/0000316709-26-000019.md) | [1.55](/filings/0000316709-26-000031.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [33.3](/filings/0000316709-24-000069.md) | [43.3](/filings/0000316709-26-000009.md) | [31.8](/filings/0000316709-25-000023.md) | [25.4](/filings/0000316709-25-000039.md) | [34.9](/filings/0000316709-25-000051.md) | [42.1](/filings/0000316709-26-000009.md) | [35.0](/filings/0000316709-26-000019.md) | [32.2](/filings/0000316709-26-000031.md) | [30.6](/filings/0000316709-25-000051.md) | [46.0](/filings/0000316709-26-000031.md) | [45.0](/filings/0000316709-26-000019.md) | [40.6](/filings/0000316709-26-000031.md) |
| Total assets | $bn | [475](/filings/0000316709-23-000062.md) | [493](/filings/0000316709-25-000010.md) | [469](/filings/0000316709-24-000044.md) | [450](/filings/0000316709-24-000060.md) | [466](/filings/0000316709-24-000069.md) | [480](/filings/0000316709-26-000009.md) | [463](/filings/0000316709-25-000023.md) | [459](/filings/0000316709-25-000039.md) | [465](/filings/0000316709-25-000051.md) | [491](/filings/0000316709-26-000031.md) | [493](/filings/0000316709-26-000019.md) | [517](/filings/0000316709-26-000031.md) |
| Total liabilities | $bn | [437](/filings/0000316709-23-000062.md) | [452](/filings/0000316709-25-000010.md) | [426](/filings/0000316709-24-000044.md) | [406](/filings/0000316709-24-000060.md) | [419](/filings/0000316709-24-000069.md) | [431](/filings/0000316709-26-000009.md) | [413](/filings/0000316709-25-000023.md) | [409](/filings/0000316709-25-000039.md) | [416](/filings/0000316709-25-000051.md) | [442](/filings/0000316709-26-000031.md) | [444](/filings/0000316709-26-000019.md) | [467](/filings/0000316709-26-000031.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [0.1](/filings/0000316709-23-000062.md) | [0.0](/filings/0000316709-25-000010.md) | [0.0](/filings/0000316709-24-000044.md) | [0.0](/filings/0000316709-24-000060.md) | [0.0](/filings/0000316709-24-000069.md) | [0.0](/filings/0000316709-26-000009.md) | [1.0](/filings/0000316709-25-000023.md) | [2.0](/filings/0000316709-25-000039.md) | [0.8](/filings/0000316709-25-000051.md) | [1.9](/filings/0000316709-26-000009.md) | not reported | not reported |
| Shareholders' equity | $bn | [37.8](/filings/0000316709-24-000069.md) | [41.0](/filings/0000316709-26-000009.md) | [42.4](/filings/0000316709-25-000039.md) | [44.0](/filings/0000316709-25-000051.md) | [47.2](/filings/0000316709-25-000051.md) | [48.4](/filings/0000316709-26-000031.md) | [49.5](/filings/0000316709-26-000031.md) | [49.5](/filings/0000316709-26-000031.md) | [49.4](/filings/0000316709-25-000051.md) | [49.4](/filings/0000316709-26-000031.md) | [49.2](/filings/0000316709-26-000031.md) | [50.1](/filings/0000316709-26-000031.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $bn | [(5.0) d](/filings/0000316709-24-000069.md) | [20.0 d](/filings/0000316709-26-000009.md) | [(1.3)](/filings/0000316709-25-000023.md) | [(4.3) d](/filings/0000316709-25-000039.md) | [19.1 d](/filings/0000316709-25-000051.md) | [(10.8) d](/filings/0000316709-26-000009.md) | [6.4](/filings/0000316709-26-000019.md) | [3.2 d](/filings/0000316709-26-000031.md) | [0.5 d](/filings/0000316709-25-000051.md) | [(0.8) d](/filings/0000316709-26-000009.md) | [7.3](/filings/0000316709-26-000019.md) | [4.3 d](/filings/0000316709-26-000031.md) |
| Capital expenditure | $bn | [0.2 d](/filings/0000316709-24-000069.md) | [0.1 d](/filings/0000316709-26-000009.md) | [0.1](/filings/0000316709-25-000023.md) | [0.1 d](/filings/0000316709-25-000039.md) | [0.1 d](/filings/0000316709-25-000051.md) | [0.3 d](/filings/0000316709-26-000009.md) | [0.1](/filings/0000316709-26-000019.md) | [0.1 d](/filings/0000316709-26-000031.md) | [0.1 d](/filings/0000316709-25-000051.md) | [0.2 d](/filings/0000316709-26-000009.md) | [0.1](/filings/0000316709-26-000019.md) | [0.2 d](/filings/0000316709-26-000031.md) |
| Dividends paid | $bn | [0.6 d](/filings/0000316709-24-000069.md) | [0.6 d](/filings/0000316709-26-000009.md) | [0.6](/filings/0000316709-25-000023.md) | [0.6 d](/filings/0000316709-25-000039.md) | [0.6 d](/filings/0000316709-25-000051.md) | [0.6 d](/filings/0000316709-26-000009.md) | [0.6](/filings/0000316709-26-000019.md) | [0.6 d](/filings/0000316709-26-000031.md) | [0.6 d](/filings/0000316709-25-000051.md) | [0.6 d](/filings/0000316709-26-000009.md) | [0.6](/filings/0000316709-26-000019.md) | [0.6 d](/filings/0000316709-26-000031.md) |
| Share repurchases | $bn | [0.0 d](/filings/0000316709-24-000069.md) | [0.0 d](/filings/0000316709-26-000009.md) | [0.0](/filings/0000316709-25-000023.md) | [0.0 d](/filings/0000316709-24-000060.md) | [0.0 d](/filings/0000316709-24-000069.md) | [0.0 d](/filings/0000316709-26-000009.md) | [1.5](/filings/0000316709-26-000019.md) | [0.3 d](/filings/0000316709-26-000031.md) | not reported | not reported | [2.4](/filings/0000316709-26-000019.md) | [1.0 d](/filings/0000316709-26-000031.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,895](/filings/0000316709-23-000062.md) | [1,842](/filings/0000316709-24-000044.md) | [1,825](/filings/0000316709-24-000060.md) | [1,827](/filings/0000316709-24-000069.md) | [1,831](/filings/0000316709-25-000023.md) | [1,834](/filings/0000316709-25-000039.md) | [1,834](/filings/0000316709-25-000051.md) | [1,822](/filings/0000316709-26-000019.md) | [1,822](/filings/0000316709-26-000031.md) | [1,811](/filings/0000316709-25-000051.md) | [1,752](/filings/0000316709-26-000019.md) | [1,739](/filings/0000316709-26-000031.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,729,335,714 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0000316709-26-000031.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.